A Study of RP-3500 in Combination With Standard Radiation Therapy in People With Solid Tumor Cancer
Status:
Recruiting
Trial end date:
2025-09-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the safety of the study drug, RP-3500 when given in
combination with palliative external beam radiotherapy (EBRT) to people who have metastatic
solid tumor cancer with a mutation of the ATM gene. The study researchers will do tests to
find the highest dose of RP3500 that causes few or mild side effects.